Cargando…
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
BACKGROUND/AIM: A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Health auth...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775681/ https://www.ncbi.nlm.nih.gov/pubmed/33078604 http://dx.doi.org/10.3906/sag-2009-77 |